Abiopharma

🔍 Schechter Adam H (Director)

Company: LABCORP HOLDINGS INC. (LH)

Report Date: 2026-02-10

Detailed Transactions and Holdings:

• Acquired 31,700 shares of Non-qualified Stock Options at $284.5 per share (Derivative)
  Date: 2026-02-10 | Code: A | Expires: 2036-02-09 | Exercise: 2027-02-10 | equity_swap_involved: 0 | shares_owned_after: 31,700.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 10,440 shares of Restricted Stock Unit (Derivative)
  Date: 2026-02-10 | Code: A | equity_swap_involved: 0 | shares_owned_after: 25,870.00 | transaction_form_type: 4 | Footnotes: F3, F4, F4, F5

Footnotes:

• F1: Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. 2025 Omnibus Incentive Plan.
• F2: The option vests in three equal annual installments beginning on the date reflected in this column.
• F3: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
• F4: The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027.
• F5: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.